L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer.
- DOI
- 10.37349/etat.2026.1002382
- Published
- 2026
- Container
- Exploration of targeted anti-tumor therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.37349/etat.2026.1002382,
title = {L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer.},
author = {Yao Y and Li Y and Gao A and Zhu C and Wang R and Li Y and Su X and Zhang M and Guo M},
year = {2026},
journal = {Exploration of targeted anti-tumor therapy},
doi = {10.37349/etat.2026.1002382},
url = {https://doi.org/10.37349/etat.2026.1002382}
}RIS
TY - JOUR TI - L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer. AU - Yao Y AU - Li Y AU - Gao A AU - Zhu C AU - Wang R AU - Li Y AU - Su X AU - Zhang M AU - Guo M PY - 2026 JO - Exploration of targeted anti-tumor therapy DO - 10.37349/etat.2026.1002382 UR - https://doi.org/10.37349/etat.2026.1002382 ER -
APA
Y, Y., Y, L., A, G., C, Z., R, W., Y, L., X, S., M, Z., & M, G. (2026). L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer.. Exploration of targeted anti-tumor therapy. https://doi.org/10.37349/etat.2026.1002382
Source records
- pubmed · retrieved 2026-09-25T20:08:52.452Z
- europe-pmc · retrieved 2026-09-25T20:08:52.463Z
- doaj · retrieved 2026-09-25T20:08:52.477Z